Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: February 2, 2023

Piramal Critical Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for PIRAMAL CRITICAL, and what generic and branded alternatives to PIRAMAL CRITICAL drugs are available?

PIRAMAL CRITICAL has twelve approved drugs.

Summary for Piramal Critical

US Patents:	0
Tradenames:	11
Ingredients:	11
NDAs:	12

Drugs and US Patents for Piramal Critical

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Piramal Critical	GABLOFEN	baclofen	INJECTABLE;INTRATHECAL	022462-001	Nov 19, 2010	AP	RX	Yes	Yes		See Plans and Pricing				See Plans and Pricing
Piramal Critical	ENFLURANE	enflurane	LIQUID;INHALATION	074396-001	Jul 29, 1994		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Piramal Critical	ROCURONIUM BROMIDE	rocuronium bromide	INJECTABLE;INJECTION	210437-001	Aug 13, 2019	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Piramal Critical	CISATRACURIUM BESYLATE	cisatracurium besylate	INJECTABLE;INJECTION	215516-001	May 24, 2022	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for PIRAMAL CRITICAL drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

McKesson

McKinsey

Boehringer Ingelheim

Harvard Business School

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.